# Emerging Global Leader Award (K43 Independent Clinical Trial Required)

Source: https://welltoldgrants.com/grants/par-24-295-emerging-global-leader-award-k43-independent-clinical-trial/  
Official notice: https://www.grants.gov/search-results-detail/356724

> National Institutes of Health is offering grants to the applicants described in the notice. Applications close on December 3, 2026.

| Field | Value |
|---|---|
| Opportunity number | PAR-24-295 |
| Agency | National Institutes of Health |
| Status | Open |
| Deadline | December 3, 2026 |
| Award ceiling | not stated |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.113, 93.172, 93.173, 93.233, 93.242, 93.279, 93.313, 93.398, 93.837, 93.838, 93.839, 93.840, 93.853, 93.866, 93.989 |

## Who can apply

- Others (see text field entitled "Additional Information on Eligibility" for clarification)

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); Applications for the K43 award must be submitted by academic education or research institutions in LMICs (as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups; low-income, lower-middle-income, and upper-middle-income countries are included). FIC's Country Eligibility Notice (NOT-TW-12-011 Notice of Change in Country Eligibility for Fogarty International Training Grants ) applies to this NOFO and states that for competing and re-competing research training grant applications (including the K43 mechanism), with the exception of Sub-Saharan African countries, FIC will no longer accept applications from, or applications that involve training of scientists from upper-middle-income countries that are also members of the G20 major economies (http://www.g20.org/en/members). For additional information see FIC's Country Eligibility page at https://www.fic.nih.gov/Grants/Pages/country-eligibility.aspx. Only non-domestic (non-U.S.) Entities (Foreign Institutions) in Low- or Middle-Income Countries are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

## What the grant funds

This is a reissue of the Emerging Global Leader Program (K43) to align with the clinical trials policy.

## Questions people ask

### Who can apply for Emerging Global Leader Award (K43 Independent Clinical Trial Required)?

National Institutes of Health accepts applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Emerging Global Leader Award (K43 Independent Clinical Trial Required)?

Closes December 3, 2026 (33 days left). Confirm the date and time in the official notice on Grants.gov.